Precision BioSciences begins dosing in Phase 1/2 FUNCTION-DMD study
Precision BioSciences says it has commenced dosing in its Phase 1/2 FUNCTION-DMD study.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.